Aurinia Pharmaceuticals Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−3.25%
vs ±8.3% implied · ×0.39
shaded = implied · ▲▼ = realized
SentenceEncapsulation Catalent Pharma Solutions ("Catalent") is currently the sole supplier for the preparation of our voclosporin capsules.
AUPH 10-Kaccession 0001600620-26-000017
SentenceManufacturing of Drug Substance Voclosporin requires a specialized drug substance manufacturing process and is manufactured by Lonza, our sole supplier for drug substance.
AUPH 10-Kaccession 0001600620-26-000017
SentenceIn addition, we sell encapsulated voclosporin to our collaboration partner, Otsuka, which Otsuka then sells to customers in the Otsuka Territories.
AUPH 10-Kaccession 0001600620-26-000017
Aurinia Pharmaceuticals has 2 disclosed suppliers and 1 disclosed customer in SEC filings.
Aurinia Pharmaceuticals Inc.
16.94
Largest filed tie
—
Expected move
No implied move.